Platelets, Coagulation and Cancer: Multifaceted Interactions

Hadi Alphonse Goubran, Thierry Pierre Robert Burnouf

Research output: Contribution to journalArticle

Abstract

Approach: Literature review of the multifaceted interactions between platelets, coagulation and cancer. Results: Over the years, the links existing between cancer development, progression and occurrence of metastasis on one side and coagulation on the other have become obvious. Tumors seems to activate platelets whereas, platelets, on the other hand, through their capacity to activate and release soluble factors and microparticles, interact with tumor cells and influence immune regulation. They appear to be key regulators of many cancer events. Furthermore, coagulation with its different facets also interplays and significantly crosstalks with malignancy. The objectives of this article are to review the mechanisms through which cancer interacts with platelets and the coagulation, triggering thrombosis and the role played by platelets and coagulation factors in the regulation of cancer and to underline the perspectives that are now open in the development of novel diagnostic tools and new cancer treatment strategies. Conclusion/Recommendations: Challenging issues and unresolved questions still need to be addressed to understand the complexity existing between coagulation factors and platelet components and the different stages of cancer progression. Recent discoveries are leading clinicians to consider new therapeutic applications of anticoagulant therapies or new drugs targeting specific platelet functions in cancer patients’ management. Furthermore, markers of coagulation and platelet activity may prove to serve as biomarkers for dormant tumors.
Original languageEnglish
Pages (from-to)130-140
JournalAmerican Medical Journal
Volume3
Publication statusPublished - 2012
Externally publishedYes

Fingerprint

Blood Platelets
Neoplasms
Blood Coagulation Factors
Drug Delivery Systems
Tumor Biomarkers
Anticoagulants
Thrombosis
Therapeutics
Neoplasm Metastasis

Keywords

  • Cancer
  • thromboses
  • coagulation
  • platelets and metastasis

Cite this

Platelets, Coagulation and Cancer : Multifaceted Interactions . / Goubran, Hadi Alphonse; Burnouf, Thierry Pierre Robert.

In: American Medical Journal, Vol. 3, 2012, p. 130-140.

Research output: Contribution to journalArticle

@article{e54b8cb4c9954fa4a2d72c892767bfe2,
title = "Platelets, Coagulation and Cancer: Multifaceted Interactions",
abstract = "Approach: Literature review of the multifaceted interactions between platelets, coagulation and cancer. Results: Over the years, the links existing between cancer development, progression and occurrence of metastasis on one side and coagulation on the other have become obvious. Tumors seems to activate platelets whereas, platelets, on the other hand, through their capacity to activate and release soluble factors and microparticles, interact with tumor cells and influence immune regulation. They appear to be key regulators of many cancer events. Furthermore, coagulation with its different facets also interplays and significantly crosstalks with malignancy. The objectives of this article are to review the mechanisms through which cancer interacts with platelets and the coagulation, triggering thrombosis and the role played by platelets and coagulation factors in the regulation of cancer and to underline the perspectives that are now open in the development of novel diagnostic tools and new cancer treatment strategies. Conclusion/Recommendations: Challenging issues and unresolved questions still need to be addressed to understand the complexity existing between coagulation factors and platelet components and the different stages of cancer progression. Recent discoveries are leading clinicians to consider new therapeutic applications of anticoagulant therapies or new drugs targeting specific platelet functions in cancer patients’ management. Furthermore, markers of coagulation and platelet activity may prove to serve as biomarkers for dormant tumors.",
keywords = "Cancer, thromboses, coagulation, platelets and metastasis",
author = "Goubran, {Hadi Alphonse} and Burnouf, {Thierry Pierre Robert}",
year = "2012",
language = "English",
volume = "3",
pages = "130--140",
journal = "American Medical Journal",

}

TY - JOUR

T1 - Platelets, Coagulation and Cancer

T2 - Multifaceted Interactions

AU - Goubran, Hadi Alphonse

AU - Burnouf, Thierry Pierre Robert

PY - 2012

Y1 - 2012

N2 - Approach: Literature review of the multifaceted interactions between platelets, coagulation and cancer. Results: Over the years, the links existing between cancer development, progression and occurrence of metastasis on one side and coagulation on the other have become obvious. Tumors seems to activate platelets whereas, platelets, on the other hand, through their capacity to activate and release soluble factors and microparticles, interact with tumor cells and influence immune regulation. They appear to be key regulators of many cancer events. Furthermore, coagulation with its different facets also interplays and significantly crosstalks with malignancy. The objectives of this article are to review the mechanisms through which cancer interacts with platelets and the coagulation, triggering thrombosis and the role played by platelets and coagulation factors in the regulation of cancer and to underline the perspectives that are now open in the development of novel diagnostic tools and new cancer treatment strategies. Conclusion/Recommendations: Challenging issues and unresolved questions still need to be addressed to understand the complexity existing between coagulation factors and platelet components and the different stages of cancer progression. Recent discoveries are leading clinicians to consider new therapeutic applications of anticoagulant therapies or new drugs targeting specific platelet functions in cancer patients’ management. Furthermore, markers of coagulation and platelet activity may prove to serve as biomarkers for dormant tumors.

AB - Approach: Literature review of the multifaceted interactions between platelets, coagulation and cancer. Results: Over the years, the links existing between cancer development, progression and occurrence of metastasis on one side and coagulation on the other have become obvious. Tumors seems to activate platelets whereas, platelets, on the other hand, through their capacity to activate and release soluble factors and microparticles, interact with tumor cells and influence immune regulation. They appear to be key regulators of many cancer events. Furthermore, coagulation with its different facets also interplays and significantly crosstalks with malignancy. The objectives of this article are to review the mechanisms through which cancer interacts with platelets and the coagulation, triggering thrombosis and the role played by platelets and coagulation factors in the regulation of cancer and to underline the perspectives that are now open in the development of novel diagnostic tools and new cancer treatment strategies. Conclusion/Recommendations: Challenging issues and unresolved questions still need to be addressed to understand the complexity existing between coagulation factors and platelet components and the different stages of cancer progression. Recent discoveries are leading clinicians to consider new therapeutic applications of anticoagulant therapies or new drugs targeting specific platelet functions in cancer patients’ management. Furthermore, markers of coagulation and platelet activity may prove to serve as biomarkers for dormant tumors.

KW - Cancer

KW - thromboses

KW - coagulation

KW - platelets and metastasis

UR - https://www.researchgate.net/publication/260471355_Platelets_Coagulation_and_Cancer_Multifaceted_Interactions

M3 - Article

VL - 3

SP - 130

EP - 140

JO - American Medical Journal

JF - American Medical Journal

ER -